Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes - PubMed (original) (raw)
doi: 10.1089/jir.2007.0049.
Giuseppe Calcagno, Vincenzo Bresciamorra, Elena Salvatore, Alessandro Filla, Silvana Capone, Rosario Liguori, Salvatore Borelli, Ivan Gentile, Francesco Borrelli, Guglielmo Borgia, Lucia Sacchetti
Affiliations
- PMID: 18338947
- DOI: 10.1089/jir.2007.0049
Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes
Giuliana Fortunato et al. J Interferon Cytokine Res. 2008 Mar.
Abstract
We have studied 35 single nucleotide polymorphisms (SNPs) in the interferon (IFN) pathway to determine their contribution to multiple sclerosis (MS) and hepatitis C virus (HCV) infection. A total of 182 patients with MS, 103 patients with chronic hepatitis C, and 118 control subjects were enrolled in the study. Of the 35 SNPs studied, 3 were in IFN-alpha receptor (IFNAR-1), 10 in IFN-alpha/beta receptor (IFNAR-2), 9 in Stat1, 5 in Stat2, and 8 in IFN regulatory factor-1 (IRF-1). Compared to controls, Stat1 gene polymorphisms were significantly more frequent in MS patients (rs# 2066802 OR = 7.46, 95% CI = 2.22-25.10; rs# 1547550 OR = 1.69, 95% CI = 1.01-2.81) and in HCV patients (rs# 2066802 OR = 5.95, 95% CI = 1.55-22.81; rs# 1547550 OR = 2.30, 95% CI = 1.24-4.24). Also one IRF-1 gene SNP was associated with MS (rs# 2070721 OR = 2.05, 95% CI = 1.03-4.09), and four IRF-1 gene SNPs were associated with HCV infection (rs# 2070721 OR = 2.59, 95% CI = 1.23-5.43; rs# 2070723 OR = 4.8, 95% CI = 1.26-18.20; rs# 2070728 OR = 9.81, 95% CI = 1.21-79.4; rs# 2070729 OR = 3.6, 95% CI = 1.23-10.48; rs# 839 OR = 4.67, 95%CI = 1.29-16.87). Characteristic nucleotide combinations on single chromosomes (haplotype) generated block structures, including SNPs, that differed between patients and controls. Using a permutation test to detect differences in haplotype distribution between groups, the CCATTGA and the CCGAA haplotypes in the IRF-1 gene were more frequent in MS (p = 0.03) and in HCV patients (p = 0.001) than in controls. In conclusion, our data show that genetic variants in the IRF-1 and Stat1 genes of the IFN pathway are associated with MS and HCV infection.
Similar articles
- Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
Abbate I, Romano M, Longo R, Cappiello G, Lo Iacono O, Di Marco V, Paparella C, Spano A, Capobianchi MR. Abbate I, et al. J Med Virol. 2003 Aug;70(4):581-7. doi: 10.1002/jmv.10433. J Med Virol. 2003. PMID: 12794720 - Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
Wietzke-Braun P, Maouzi AB, Mänhardt LB, Bickeböller H, Ramadori G, Mihm S. Wietzke-Braun P, et al. Eur J Gastroenterol Hepatol. 2006 Sep;18(9):991-7. doi: 10.1097/01.meg.0000224478.89545.76. Eur J Gastroenterol Hepatol. 2006. PMID: 16894313 - Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
Bautista D, Bermúdez-Silva FJ, Lasarte JJ, Rodriguez-Fonseca F, Baixeras E. Bautista D, et al. J Pathol. 2007 Nov;213(3):347-55. doi: 10.1002/path.2214. J Pathol. 2007. PMID: 17940994 - Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H, Al-Mars A, Chaudhary A, Abuzenadah A, Damanhouri G, Alqahtani M, Mahmoud M, El Sayed Zaki M, Fatima K, Qadri I. Qashqari H, et al. Infect Genet Evol. 2013 Oct;19:113-9. doi: 10.1016/j.meegid.2013.06.025. Epub 2013 Jul 5. Infect Genet Evol. 2013. PMID: 23831932 Review. - Role of differential expression of interferon receptor isoforms on the response of multiple sclerosis patients to therapy with interferon beta.
Gilli F. Gilli F. J Interferon Cytokine Res. 2010 Oct;30(10):733-41. doi: 10.1089/jir.2010.0098. J Interferon Cytokine Res. 2010. PMID: 20874250 Review.
Cited by
- Mechanisms Governing Oligodendrocyte Viability in Multiple Sclerosis and Its Animal Models.
Lei Z, Lin W. Lei Z, et al. Cells. 2024 Jan 9;13(2):116. doi: 10.3390/cells13020116. Cells. 2024. PMID: 38247808 Free PMC article. Review. - Transcriptomic Analysis of Fumarate Compounds Identifies Unique Effects of Isosorbide Di-(Methyl Fumarate) on NRF2, NF-kappaB and IRF1 Pathway Genes.
Swindell WR, Bojanowski K, Chaudhuri RK. Swindell WR, et al. Pharmaceuticals (Basel). 2022 Apr 11;15(4):461. doi: 10.3390/ph15040461. Pharmaceuticals (Basel). 2022. PMID: 35455458 Free PMC article. - Heparanome-Mediated Rescue of Oligodendrocyte Progenitor Quiescence following Inflammatory Demyelination.
Saraswat D, Welliver RR, Ravichandar R, Tripathi A, Polanco JJ, Broome J, Hurley E, Dutta R, Feltri ML, Sim FJ. Saraswat D, et al. J Neurosci. 2021 Mar 10;41(10):2245-2263. doi: 10.1523/JNEUROSCI.0580-20.2021. Epub 2021 Jan 20. J Neurosci. 2021. PMID: 33472827 Free PMC article. - Novel association between TGFA, TGFB1, IRF1, PTGS2 and IKBKB single-nucleotide polymorphisms and occurrence, severity and treatment response of major depressive disorder.
Bialek K, Czarny P, Watala C, Wigner P, Talarowska M, Galecki P, Szemraj J, Sliwinski T. Bialek K, et al. PeerJ. 2020 Feb 25;8:e8676. doi: 10.7717/peerj.8676. eCollection 2020. PeerJ. 2020. PMID: 32140313 Free PMC article. - Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study.
Söderholm J, Yilmaz A, Svenningsson A, Büsch K, Wejstål R, Brolund A, Kövamees J, Sällberg M, Lagging M, Gisslén M. Söderholm J, et al. J Neurol. 2019 Sep;266(9):2208-2215. doi: 10.1007/s00415-019-09397-8. Epub 2019 May 31. J Neurol. 2019. PMID: 31152298 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous